March 26, 2020
SOUTH SAN FRANCISCO, Calif.-- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a collaboration with Vanderbilt University Medical Center (VUMC) to supply synthetic genes and antibodies for the development of therapies for COVID-19. In addition, Twist Biopharma, a division [...]
Tecan announces change in Management Board
March 26, 2020
Männedorf, Switzerland– The Tecan Group (SIX Swiss Exchange: TECN) announced today that Markus Schmid, Head of Corporate Human Resources & Internal Communications and a member of the Group Management Board since 2011, will leave the company by no later than the end of April 2020. The search for a successor will be initiated. Tecan's Board of Directors [...]
INTEGRA, BioTools and Sullivan Nicolaides Pathology work together to accelerate COVID-19 testing
March 26, 2020
INTEGRA, BioTools and Sullivan Nicolaides Pathology work together to accelerate COVID-19 testing The global COVID-19 pandemic has placed unprecedented demands on pathology services to test patient samples for the novel SARS-CoV-2 coronavirus alongside their pre-existing respiratory virus panels. This extreme influx of samples quickly exhausted the capacity of existing systems in the Microbiology and Molecular Pathology Department at Sullivan Nicolaides Pathology (SNP) – part of [...]
ZAGENO Releases COVID-19 Data Addressing the Laboratory Supply Chain
March 25, 2020
CAMBRIDGE, Mass. and BERLIN -- ZAGENO, a leading enterprise marketplace solution connecting e-commerce to life science, today shared COVID-19-related data, which reveals the readiness and short-term impact to both supplier and biotech laboratory teams and the long-term implications of an industry disruption caused by a pandemic. Volumes have increased, considerably. Q1, year-over-year (2019-2020) volumes by [...]
QIAGEN Names Thierry Bernard as Chief Executive Officer
March 25, 2020
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that Thierry Bernard has been named Chief Executive Officer. Additionally, a Joint Meeting of the Supervisory Board and the Managing Board has resolved to propose Mr. Bernard, who has been with QIAGEN since 2015, for election as Chief Executive Officer and a Managing Director at the [...]
Picarro Announces New Airborne Molecular Contamination Monitoring System for Semiconductor Fabs
March 25, 2020
SANTA CLARA, Calif., -- Picarro announces the launch of our fully optimized AMC monitoring system – the Picarro SAM (Sample. Analyze. Monitor.) The system is comprised of Picarro's industry leading CRDS-based sensor integrated into a state-of-the-art sampling system. The SAM unit provides high throughput sampling without compromising the performance of the sensor. The new Picarro [...]
FLUROTECH ANNOUNCES A NEW EASTERN US FOCUSED DISTRIBUTOR
March 25, 2020
Calgary, Alberta, – FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), a technology company focused on becoming the standard in the analytical Cannabis and Hemp testing market, is pleased to announce it has entered into an non-exclusive US distribution agreement with North Carolina based HempLab Inc. The distribution agreement provides for FluroTech and HempLab to work together [...]
March 25, 2020
SHANGHAI, China,-- Sartorius, a leading international partner of life science research and the biopharmaceutical industry, has supported CanSino Biologics Inc. (“CanSinoBIO”) and Maj. Gen. Chen Wei’s team at the Institute of Bioengineering at the Academy of Military Medical Sciences (“Institute of Bioengineering”) in China in their development of the first vaccine candidate against the novel coronavirus [...]
March 25, 2020
Proteona leads international consortium to develop SARS-CoV-2 neutralizing antibody to help vulnerable immunocompromised individuals Innovative AI-driven proteogenomic analysis company applies single cell analysis expertise to developing treatments for COVID-19 The Proteona team is leveraging on its ESCAPE™ single cell proteogenomics platform to discover SARS-CoV-2 neutralizing antibodies. Singapore, 25 March 2020 - Proteona Pte. Ltd. and partners [...]
BIO-TECHNE’S ELLA ON THE FRONT LINES IN FIGHT AGAINST COVID-19
March 25, 2020
MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ:TECH) today shared news from clinical partners on the use of the ProteinSimple-branded Ella Automated Immunoassay platform in the fight against COVID-19. In a March 23, 2020 press release, the Icahn School of Medicine, Mount Sinai announced that they are utilizing Bio-Techne's Ella Automated Immunoassay Platform to monitor individual immune responses [...]

